Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QEEG Prediction of SSRI Response in MDD
NCT00917059Phase 4Completed
- Sponsor
- University of California, Los Angeles
- Start
- May 2009
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram in major depressive disorder (MDD), sponsored by University of California, Los Angeles. Started May 2009; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00917059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00917059.